Clinical trials
Not yet recruiting Phase 3 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 11 |
| 2026 | 22 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 9 |
| Alexandria University | 1 |
| CSPC Megalith Biopharmaceutical Co.,Ltd. | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Chengdu JOYO pharma Co., Ltd. | 1 |
| D'Or Institute for Research and Education | 1 |
| European Institute of Oncology | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Franciscus Gasthuis & Vlietland (Hospital) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 43 |
| Triple Negative Breast Neoplasms | 6 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Lung Diseases, Interstitial | 1 |
| Musculoskeletal Pain | 1 |
| Neoplasm Metastasis | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.